IndraLab

Statements

USP19 ubiquitinates TRAF2. 1 / 1

| 1

reach

"Interestingly, USP19 which constitutively de-ubiquitinylates and disables c-IAP-1 from ubiquitinating and targeting TRAF2 for proteasomal degradation was also reduced in cardiac myocytes treated with doxorubicin - a finding concordant with impaired NF-κB activation."

35983756

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP19 ubiquitinates TRAF2. 1 / 1

INDRA sources:

Databases

Reading